Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-α, IL-1, and RANKL

Journal of Cellular Physiology

Volumn 190, Issue 1, 2002, Pages 101-108

  Suda, Koji ^a   Woo, Je Tae ^a   Takami, Masamichi ^a   Sexton, Patrick M ^b   Nagai, Kazuo ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN RECEPTOR; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LACTACYSTIN; LIGAND; LIPOPOLYSACCHARIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL FUSION; CELL STIMULATION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MONONUCLEAR CELL; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL ADHESION MOLECULES; CELL FUSION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CYSTEINE ENDOPEPTIDASES; DENTIN; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GIANT CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MICE; MULTIENZYME COMPLEXES; NF-KAPPA B; OSTEOCLASTS; PROTEASOME ENDOPEPTIDASE COMPLEX; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

NEGIBACTERIA;

EID: 0036132249     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10041     Document Type: Article

References (38)

1. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor
2. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
3. The NF-®B and IκB proteins: New discoveries and insights
4. An essential role for NF-κB in preventing TNF-α-induced cell death
5. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
6. Cutting edge: Toll-like receptor 4 (TLRA)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
7. Lipopolysaccharides from Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans promote osteoclastic differentiation in vitro
8. Macrophage colony-stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells
9. Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1
10. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
11. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells
12. Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue
13. Unresponsiveness of MyD88-deficient mice to endotoxin
14. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
15. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
16. Lipopolysaccharide antagonists
17. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts
18. Bacterially induced bone destruction: Mechanisms and misconceptions
19. NF-κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells
20. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line
21. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in T1r4 gene
22. Calcitonin receptor antibodies in the identification of osteoclasts
23. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (T1r4)
24. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines, and lipopolysaccharide
25. Molecular mechanisms of endotoxin activity
26. Structure, regulation, and function of NF-κB
27. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
28. 3 in osteoclast differentiation and function
29. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
30. Requirement of osteoblastic cells for the fusion of osteoclasts
31. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production
32. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
33. 2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4
34. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
35. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
36. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src
37. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
38. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes